Literature DB >> 33557041

De Novo PORCN and ZIC2 Mutations in a Highly Consanguineous Family.

Laura Castilla-Vallmanya1, Semra Gürsoy2, Özlem Giray-Bozkaya3, Aina Prat-Planas1, Gemma Bullich4, Leslie Matalonga4, Mónica Centeno-Pla1, Raquel Rabionet1, Daniel Grinberg1, Susanna Balcells1, Roser Urreizti1.   

Abstract

We present a Turkish family with two cousins (OC15 and OC15b) affected with syndromic developmental delay, microcephaly, and trigonocephaly but with some phenotypic traits distinct between them. OC15 showed asymmetrical skeletal defects and syndactyly, while OC15b presented with a more severe microcephaly and semilobal holoprosencephaly. All four progenitors were related and OC15 parents were consanguineous. Whole Exome Sequencing (WES) analysis was performed on patient OC15 as a singleton and on the OC15b trio. Selected variants were validated by Sanger sequencing. We did not identify any shared variant that could be associated with the disease. Instead, each patient presented a de novo heterozygous variant in a different gene. OC15 carried a nonsense mutation (p.Arg95*) in PORCN, which is a gene responsible for Goltz-Gorlin syndrome, while OC15b carried an indel mutation in ZIC2 leading to the substitution of three residues by a proline (p.His404_Ser406delinsPro). Autosomal dominant mutations in ZIC2 have been associated with holoprosencephaly 5. Both variants are absent in the general population and are predicted to be pathogenic. These two de novo heterozygous variants identified in the two patients seem to explain the major phenotypic alterations of each particular case, instead of a homozygous variant that would be expected by the underlying consanguinity.

Entities:  

Keywords:  clinical genetics; consanguinity; focal dermal hypoplasia; holoprosencephaly; neurodevelopmental disease; whole exome sequencing

Mesh:

Substances:

Year:  2021        PMID: 33557041      PMCID: PMC7913830          DOI: 10.3390/ijms22041549

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  31 in total

1.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.

Authors:  Manabu Kurayoshi; Hideki Yamamoto; Shunsuke Izumi; Akira Kikuchi
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

2.  In vitro analysis of partial loss-of-function ZIC2 mutations in holoprosencephaly: alanine tract expansion modulates DNA binding and transactivation.

Authors:  Lucia Brown; Melinda Paraso; Ruth Arkell; Stephen Brown
Journal:  Hum Mol Genet       Date:  2004-12-08       Impact factor: 6.150

Review 3.  Characteristics of genetic diseases in consanguineous populations in the genomic era: Lessons from Arab communities in North Israel.

Authors:  S A Shalev
Journal:  Clin Genet       Date:  2018-03-13       Impact factor: 4.438

4.  The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism.

Authors:  Erich Roessler; Felicitas Lacbawan; Christèle Dubourg; Aimee Paulussen; Jos Herbergs; Ute Hehr; Claude Bendavid; Nan Zhou; Maia Ouspenskaia; Sherri Bale; Sylvie Odent; Vèronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

5.  Autosomal recessive mutations in nuclear transport factor KPNA7 are associated with infantile spasms and cerebellar malformation.

Authors:  Alex R Paciorkowski; Judy Weisenberg; Joshua B Kelley; Adam Spencer; Emily Tuttle; Dalia Ghoneim; Liu Lin Thio; Susan L Christian; William B Dobyns; Bryce M Paschal
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

6.  Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine.

Authors:  Xinxin Gao; Rami N Hannoush
Journal:  Nat Chem Biol       Date:  2013-11-24       Impact factor: 15.040

7.  A Zic2-regulated switch in a noncanonical Wnt/βcatenin pathway is essential for the formation of bilateral circuits.

Authors:  Cruz Morenilla-Palao; María Teresa López-Cascales; José P López-Atalaya; Diana Baeza; Luís Calvo-Díaz; Angel Barco; Eloísa Herrera
Journal:  Sci Adv       Date:  2020-11-13       Impact factor: 14.136

8.  Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery.

Authors:  Eric M Scott; Anason Halees; Yuval Itan; Emily G Spencer; Yupeng He; Mostafa Abdellateef Azab; Stacey B Gabriel; Aziz Belkadi; Bertrand Boisson; Laurent Abel; Andrew G Clark; Fowzan S Alkuraya; Jean-Laurent Casanova; Joseph G Gleeson
Journal:  Nat Genet       Date:  2016-07-18       Impact factor: 38.330

9.  Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development.

Authors:  Michael S Nahorski; Sateesh Maddirevula; Ryosuke Ishimura; Saud Alsahli; Angela F Brady; Anaïs Begemann; Tsunehiro Mizushima; Francisco J Guzmán-Vega; Miki Obata; Yoshinobu Ichimura; Hessa S Alsaif; Shams Anazi; Niema Ibrahim; Firdous Abdulwahab; Mais Hashem; Dorota Monies; Mohamed Abouelhoda; Brian F Meyer; Majid Alfadhel; Wafa Eyaid; Markus Zweier; Katharina Steindl; Anita Rauch; Stefan T Arold; C Geoffrey Woods; Masaaki Komatsu; Fowzan S Alkuraya
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

10.  Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum.

Authors:  Roser Urreizti; Estrella Lopez-Martin; Antonio Martinez-Monseny; Montse Pujadas; Laura Castilla-Vallmanya; Luis Alberto Pérez-Jurado; Mercedes Serrano; Daniel Natera-de Benito; Beatriz Martínez-Delgado; Manuel Posada-de-la-Paz; Javier Alonso; Purificación Marin-Reina; Mar O'Callaghan; Daniel Grinberg; Eva Bermejo-Sánchez; Susanna Balcells
Journal:  Orphanet J Rare Dis       Date:  2020-02-10       Impact factor: 4.123

View more
  2 in total

Review 1.  Congenital Microcoria: Clinical Features and Molecular Genetics.

Authors:  Clémentine Angée; Brigitte Nedelec; Elisa Erjavec; Jean-Michel Rozet; Lucas Fares Taie
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

2.  Molecular Research in Medical Genetics.

Authors:  Emanuela Viggiano
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.